Transpupillary thermotherapy of subfoveal occult choroidal neovascularization

Adam H. Rogers, Elias Reichel, Adam Martidis, Audina Berrocal

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

TTT is emerging as a treatment for occult choroidal neovascularization. By penetrating deep in the choroid with infrared light at 810 mm, TTT causes heat-induced damage to the neovascular tissue while limiting injury to the neurosensory retina. Multiple pilot studies have confirmed that TTT is useful in stabilizing the visual acuity in eyes with occult CNV. Recent pilot studies have identified that TTT stabilizes visual acuity in eyes treated with classic CNV. The use of TTT to treat occult CNV is currently under investigation in the TTT4CNV trial.

Original languageEnglish (US)
Title of host publicationAge-Related Macular Degeneration
PublisherCRC Press
Pages259-265
Number of pages7
ISBN (Electronic)9780203909157
ISBN (Print)9780824706821
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Choroidal Neovascularization
Induced Hyperthermia
Visual Acuity
Choroid
Retina
Hot Temperature
Light
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rogers, A. H., Reichel, E., Martidis, A., & Berrocal, A. (2002). Transpupillary thermotherapy of subfoveal occult choroidal neovascularization. In Age-Related Macular Degeneration (pp. 259-265). CRC Press.

Transpupillary thermotherapy of subfoveal occult choroidal neovascularization. / Rogers, Adam H.; Reichel, Elias; Martidis, Adam; Berrocal, Audina.

Age-Related Macular Degeneration. CRC Press, 2002. p. 259-265.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rogers, AH, Reichel, E, Martidis, A & Berrocal, A 2002, Transpupillary thermotherapy of subfoveal occult choroidal neovascularization. in Age-Related Macular Degeneration. CRC Press, pp. 259-265.
Rogers AH, Reichel E, Martidis A, Berrocal A. Transpupillary thermotherapy of subfoveal occult choroidal neovascularization. In Age-Related Macular Degeneration. CRC Press. 2002. p. 259-265
Rogers, Adam H. ; Reichel, Elias ; Martidis, Adam ; Berrocal, Audina. / Transpupillary thermotherapy of subfoveal occult choroidal neovascularization. Age-Related Macular Degeneration. CRC Press, 2002. pp. 259-265
@inbook{a552b1cc3e764307bc3d58ad59a982e1,
title = "Transpupillary thermotherapy of subfoveal occult choroidal neovascularization",
abstract = "TTT is emerging as a treatment for occult choroidal neovascularization. By penetrating deep in the choroid with infrared light at 810 mm, TTT causes heat-induced damage to the neovascular tissue while limiting injury to the neurosensory retina. Multiple pilot studies have confirmed that TTT is useful in stabilizing the visual acuity in eyes with occult CNV. Recent pilot studies have identified that TTT stabilizes visual acuity in eyes treated with classic CNV. The use of TTT to treat occult CNV is currently under investigation in the TTT4CNV trial.",
author = "Rogers, {Adam H.} and Elias Reichel and Adam Martidis and Audina Berrocal",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780824706821",
pages = "259--265",
booktitle = "Age-Related Macular Degeneration",
publisher = "CRC Press",

}

TY - CHAP

T1 - Transpupillary thermotherapy of subfoveal occult choroidal neovascularization

AU - Rogers, Adam H.

AU - Reichel, Elias

AU - Martidis, Adam

AU - Berrocal, Audina

PY - 2002/1/1

Y1 - 2002/1/1

N2 - TTT is emerging as a treatment for occult choroidal neovascularization. By penetrating deep in the choroid with infrared light at 810 mm, TTT causes heat-induced damage to the neovascular tissue while limiting injury to the neurosensory retina. Multiple pilot studies have confirmed that TTT is useful in stabilizing the visual acuity in eyes with occult CNV. Recent pilot studies have identified that TTT stabilizes visual acuity in eyes treated with classic CNV. The use of TTT to treat occult CNV is currently under investigation in the TTT4CNV trial.

AB - TTT is emerging as a treatment for occult choroidal neovascularization. By penetrating deep in the choroid with infrared light at 810 mm, TTT causes heat-induced damage to the neovascular tissue while limiting injury to the neurosensory retina. Multiple pilot studies have confirmed that TTT is useful in stabilizing the visual acuity in eyes with occult CNV. Recent pilot studies have identified that TTT stabilizes visual acuity in eyes treated with classic CNV. The use of TTT to treat occult CNV is currently under investigation in the TTT4CNV trial.

UR - http://www.scopus.com/inward/record.url?scp=16844375925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844375925&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:16844375925

SN - 9780824706821

SP - 259

EP - 265

BT - Age-Related Macular Degeneration

PB - CRC Press

ER -